Abstract / Description of output
The principal inhibitor of fibrinolysis in vivo is plasminogen activator inhibitor-1 (PAI-1). PAI-749 is a small molecule inhibitor of PAI-1 with proven antithrombotic efficacy in several preclinical models.
Original language | English |
---|---|
Pages (from-to) | 1333-9 |
Number of pages | 7 |
Journal | Journal of Thrombosis and Haemostasis |
Volume | 8 |
Issue number | 6 |
DOIs | |
Publication status | Published - 2010 |